KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Assets (2016 - 2025)

Amgen (AMGN) has 17 years of Assets data on record, last reported at $90.6 billion in Q4 2025.

  • For Q4 2025, Assets fell 1.36% year-over-year to $90.6 billion; the TTM value through Dec 2025 reached $90.6 billion, down 1.36%, while the annual FY2025 figure was $90.6 billion, 1.36% down from the prior year.
  • Assets reached $90.6 billion in Q4 2025 per AMGN's latest filing, roughly flat from $90.1 billion in the prior quarter.
  • Across five years, Assets topped out at $97.2 billion in Q4 2023 and bottomed at $59.2 billion in Q1 2022.
  • Average Assets over 5 years is $79.4 billion, with a median of $89.0 billion recorded in 2023.
  • Peak YoY movement for Assets: decreased 8.06% in 2021, then soared 52.24% in 2023.
  • A 5-year view of Assets shows it stood at $61.2 billion in 2021, then increased by 6.47% to $65.1 billion in 2022, then surged by 49.19% to $97.2 billion in 2023, then decreased by 5.47% to $91.8 billion in 2024, then fell by 1.36% to $90.6 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Assets were $90.6 billion in Q4 2025, $90.1 billion in Q3 2025, and $87.9 billion in Q2 2025.